Logo image
Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus
Journal article   Open access   Peer reviewed

Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus

Ying Rong, Wei Bao, Zhilei Shan, Jun Liu, Xuefeng Yu, Songfan Xia, Hui Gao, Xia Wang, Ping Yao, Frank B Hu, …
PloS one, Vol.8(9), pp.e73272-e73272
2013
DOI: 10.1371/journal.pone.0073272
PMCID: PMC3759444
PMID: 24023848
url
https://doi.org/10.1371/journal.pone.0073272View
Published (Version of record) Open Access

Abstract

MicroRNAs (miRNAs), a class of small non-coding RNAs, are thought to serve as crucial regulators of gene expression. Dysregulated expression of miRNAs has been described in various diseases and may contribute to related pathologic processes. Our aim was to examine circulating miRNA-146a levels in newly diagnosed type 2 diabetes mellitus (new-T2DM) patients from a Chinese Han population. Circulating miRNA-146a was extracted from plasma samples of 90 new-T2DM patients and 90 age- and sex-matched controls. Quantitative PCR assessment revealed that circulating miRNA-146a levels were significantly elevated in new-T2DM patients compared with controls. Participants in the highest tertile of circulating miRNA-146a levels showed a notably higher risk for new-T2DM (crude OR 4.333, 95% CI, 1.935 to 9.705, P = 0.001) than persons in the lowest tertile. Controlling for known risk factors and some biochemical indicators did not attenuate the aforementioned association. In addition, receiver operating characteristic (ROC) curves generated for miRNA-146a revealed an area under the curve (AUC) of 0.725 (95% CI, 0.651 to 0.799, P < 0.001). Moreover, higher circulating miRNA-146a levels were significantly associated with higher plasma heme oxygenase-1 (HO-1) concentrations (β coefficient = 0.131, P < 0.001) and lower HOMA-beta (β coefficient = -0.153, P = 0.015). We found that circulating miRNA-146a levels were significantly elevated in new-T2DM patients compared with healthy controls. Whether expression of circulating miRNA-146a holds predictive value for T2DM warrants further investigations.
Heme Oxygenase-1 - blood Disease Susceptibility Diabetes Mellitus, Type 2 - genetics Humans Middle Aged Diabetes Mellitus, Type 2 - enzymology Male Case-Control Studies Diabetes Mellitus, Type 2 - diagnosis Asian Continental Ancestry Group Diabetes Mellitus, Type 2 - blood Adult Female ROC Curve MicroRNAs - blood

Details

Metrics

Logo image